0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global GABAB Receptor Agonists Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-35Y18877
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global GABAB Receptor Agonists Market Research Report 2025
BUY CHAPTERS

Global GABAB Receptor Agonists Market Research Report 2025

Code: QYRE-Auto-35Y18877
Report
February 2025
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

GABAB Receptor Agonists Market Size

The global market for GABAB Receptor Agonists was valued at US$ 669 million in the year 2024 and is projected to reach a revised size of US$ 1507 million by 2031, growing at a CAGR of 11.5% during the forecast period.

GABAB Receptor Agonists Market

GABAB Receptor Agonists Market

GABAB receptor agonists are compounds that bind to and activate GABAB​ receptors. By enhancing the inhibitory effects of GABABreceptors, they modulate neurotransmission, typically exhibiting pharmacological effects such as analgesia, anxiolysis, and antispasmodic properties.
North American market for GABAB Receptor Agonists is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for GABAB Receptor Agonists is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of GABAB Receptor Agonists include Novartis, Hikma, Viatris, Jazz Pharmaceuicals, Sun Pharma, Fuan Pharmaceutical Group, Nanjing Haina Pharmaceutical, Chengdu Beite, Hemony Pharmaceutical, Xi'an Hanfeng Pharmaceuticals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for GABAB Receptor Agonists, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding GABAB Receptor Agonists.
The GABAB Receptor Agonists market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global GABAB Receptor Agonists market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the GABAB Receptor Agonists manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of GABAB Receptor Agonists Market Report

Report Metric Details
Report Name GABAB Receptor Agonists Market
Accounted market size in year US$ 669 million
Forecasted market size in 2031 US$ 1507 million
CAGR 11.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novartis, Hikma, Viatris, Jazz Pharmaceuicals, Sun Pharma, Fuan Pharmaceutical Group, Nanjing Haina Pharmaceutical, Chengdu Beite, Hemony Pharmaceutical, Xi'an Hanfeng Pharmaceuticals, Sichuan Ren'an Pharmaceuticals, China Resources Double Crane Pharmaceuticals, Xi'an Libang Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of GABAB Receptor Agonists manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of GABAB Receptor Agonists in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is GABAB Receptor Agonists Market growing?

Ans: The GABAB Receptor Agonists Market witnessing a CAGR of 11.5% during the forecast period 2025-2031.

What is the GABAB Receptor Agonists Market size in 2031?

Ans: The GABAB Receptor Agonists Market size in 2031 will be US$ 1507 million.

Who are the main players in the GABAB Receptor Agonists Market report?

Ans: The main players in the GABAB Receptor Agonists Market are Novartis, Hikma, Viatris, Jazz Pharmaceuicals, Sun Pharma, Fuan Pharmaceutical Group, Nanjing Haina Pharmaceutical, Chengdu Beite, Hemony Pharmaceutical, Xi'an Hanfeng Pharmaceuticals, Sichuan Ren'an Pharmaceuticals, China Resources Double Crane Pharmaceuticals, Xi'an Libang Pharmaceuticals

What are the Application segmentation covered in the GABAB Receptor Agonists Market report?

Ans: The Applications covered in the GABAB Receptor Agonists Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the GABAB Receptor Agonists Market report?

Ans: The Types covered in the GABAB Receptor Agonists Market report are Baclofen, γ-hydroxybutyrate(GHB))

Recommended Reports

Neuroactive Drugs

Receptor Modulators

Neurologic Disorders

1 GABAB Receptor Agonists Market Overview
1.1 Product Definition
1.2 GABAB Receptor Agonists by Type
1.2.1 Global GABAB Receptor Agonists Market Value Comparison by Type (2024 VS 2031)
1.2.2 Baclofen
1.2.3 γ-hydroxybutyrate(GHB))
1.3 GABAB Receptor Agonists by Application
1.3.1 Global GABAB Receptor Agonists Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global GABAB Receptor Agonists Market Size Estimates and Forecasts
1.4.1 Global GABAB Receptor Agonists Revenue 2020-2031
1.4.2 Global GABAB Receptor Agonists Sales 2020-2031
1.4.3 Global GABAB Receptor Agonists Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 GABAB Receptor Agonists Market Competition by Manufacturers
2.1 Global GABAB Receptor Agonists Sales Market Share by Manufacturers (2020-2025)
2.2 Global GABAB Receptor Agonists Revenue Market Share by Manufacturers (2020-2025)
2.3 Global GABAB Receptor Agonists Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of GABAB Receptor Agonists, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of GABAB Receptor Agonists, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of GABAB Receptor Agonists, Product Type & Application
2.7 Global Key Manufacturers of GABAB Receptor Agonists, Date of Enter into This Industry
2.8 Global GABAB Receptor Agonists Market Competitive Situation and Trends
2.8.1 Global GABAB Receptor Agonists Market Concentration Rate
2.8.2 The Global 5 and 10 Largest GABAB Receptor Agonists Players Market Share by Revenue
2.8.3 Global GABAB Receptor Agonists Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global GABAB Receptor Agonists Market Scenario by Region
3.1 Global GABAB Receptor Agonists Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global GABAB Receptor Agonists Sales by Region: 2020-2031
3.2.1 Global GABAB Receptor Agonists Sales by Region: 2020-2025
3.2.2 Global GABAB Receptor Agonists Sales by Region: 2026-2031
3.3 Global GABAB Receptor Agonists Revenue by Region: 2020-2031
3.3.1 Global GABAB Receptor Agonists Revenue by Region: 2020-2025
3.3.2 Global GABAB Receptor Agonists Revenue by Region: 2026-2031
3.4 North America GABAB Receptor Agonists Market Facts & Figures by Country
3.4.1 North America GABAB Receptor Agonists Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America GABAB Receptor Agonists Sales by Country (2020-2031)
3.4.3 North America GABAB Receptor Agonists Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe GABAB Receptor Agonists Market Facts & Figures by Country
3.5.1 Europe GABAB Receptor Agonists Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe GABAB Receptor Agonists Sales by Country (2020-2031)
3.5.3 Europe GABAB Receptor Agonists Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific GABAB Receptor Agonists Market Facts & Figures by Region
3.6.1 Asia Pacific GABAB Receptor Agonists Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific GABAB Receptor Agonists Sales by Region (2020-2031)
3.6.3 Asia Pacific GABAB Receptor Agonists Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America GABAB Receptor Agonists Market Facts & Figures by Country
3.7.1 Latin America GABAB Receptor Agonists Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America GABAB Receptor Agonists Sales by Country (2020-2031)
3.7.3 Latin America GABAB Receptor Agonists Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa GABAB Receptor Agonists Market Facts & Figures by Country
3.8.1 Middle East and Africa GABAB Receptor Agonists Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa GABAB Receptor Agonists Sales by Country (2020-2031)
3.8.3 Middle East and Africa GABAB Receptor Agonists Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global GABAB Receptor Agonists Sales by Type (2020-2031)
4.1.1 Global GABAB Receptor Agonists Sales by Type (2020-2025)
4.1.2 Global GABAB Receptor Agonists Sales by Type (2026-2031)
4.1.3 Global GABAB Receptor Agonists Sales Market Share by Type (2020-2031)
4.2 Global GABAB Receptor Agonists Revenue by Type (2020-2031)
4.2.1 Global GABAB Receptor Agonists Revenue by Type (2020-2025)
4.2.2 Global GABAB Receptor Agonists Revenue by Type (2026-2031)
4.2.3 Global GABAB Receptor Agonists Revenue Market Share by Type (2020-2031)
4.3 Global GABAB Receptor Agonists Price by Type (2020-2031)
5 Segment by Application
5.1 Global GABAB Receptor Agonists Sales by Application (2020-2031)
5.1.1 Global GABAB Receptor Agonists Sales by Application (2020-2025)
5.1.2 Global GABAB Receptor Agonists Sales by Application (2026-2031)
5.1.3 Global GABAB Receptor Agonists Sales Market Share by Application (2020-2031)
5.2 Global GABAB Receptor Agonists Revenue by Application (2020-2031)
5.2.1 Global GABAB Receptor Agonists Revenue by Application (2020-2025)
5.2.2 Global GABAB Receptor Agonists Revenue by Application (2026-2031)
5.2.3 Global GABAB Receptor Agonists Revenue Market Share by Application (2020-2031)
5.3 Global GABAB Receptor Agonists Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Company Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis GABAB Receptor Agonists Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novartis GABAB Receptor Agonists Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Hikma
6.2.1 Hikma Company Information
6.2.2 Hikma Description and Business Overview
6.2.3 Hikma GABAB Receptor Agonists Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Hikma GABAB Receptor Agonists Product Portfolio
6.2.5 Hikma Recent Developments/Updates
6.3 Viatris
6.3.1 Viatris Company Information
6.3.2 Viatris Description and Business Overview
6.3.3 Viatris GABAB Receptor Agonists Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Viatris GABAB Receptor Agonists Product Portfolio
6.3.5 Viatris Recent Developments/Updates
6.4 Jazz Pharmaceuicals
6.4.1 Jazz Pharmaceuicals Company Information
6.4.2 Jazz Pharmaceuicals Description and Business Overview
6.4.3 Jazz Pharmaceuicals GABAB Receptor Agonists Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Jazz Pharmaceuicals GABAB Receptor Agonists Product Portfolio
6.4.5 Jazz Pharmaceuicals Recent Developments/Updates
6.5 Sun Pharma
6.5.1 Sun Pharma Company Information
6.5.2 Sun Pharma Description and Business Overview
6.5.3 Sun Pharma GABAB Receptor Agonists Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Sun Pharma GABAB Receptor Agonists Product Portfolio
6.5.5 Sun Pharma Recent Developments/Updates
6.6 Fuan Pharmaceutical Group
6.6.1 Fuan Pharmaceutical Group Company Information
6.6.2 Fuan Pharmaceutical Group Description and Business Overview
6.6.3 Fuan Pharmaceutical Group GABAB Receptor Agonists Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Fuan Pharmaceutical Group GABAB Receptor Agonists Product Portfolio
6.6.5 Fuan Pharmaceutical Group Recent Developments/Updates
6.7 Nanjing Haina Pharmaceutical
6.7.1 Nanjing Haina Pharmaceutical Company Information
6.7.2 Nanjing Haina Pharmaceutical Description and Business Overview
6.7.3 Nanjing Haina Pharmaceutical GABAB Receptor Agonists Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Nanjing Haina Pharmaceutical GABAB Receptor Agonists Product Portfolio
6.7.5 Nanjing Haina Pharmaceutical Recent Developments/Updates
6.8 Chengdu Beite
6.8.1 Chengdu Beite Company Information
6.8.2 Chengdu Beite Description and Business Overview
6.8.3 Chengdu Beite GABAB Receptor Agonists Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Chengdu Beite GABAB Receptor Agonists Product Portfolio
6.8.5 Chengdu Beite Recent Developments/Updates
6.9 Hemony Pharmaceutical
6.9.1 Hemony Pharmaceutical Company Information
6.9.2 Hemony Pharmaceutical Description and Business Overview
6.9.3 Hemony Pharmaceutical GABAB Receptor Agonists Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Hemony Pharmaceutical GABAB Receptor Agonists Product Portfolio
6.9.5 Hemony Pharmaceutical Recent Developments/Updates
6.10 Xi'an Hanfeng Pharmaceuticals
6.10.1 Xi'an Hanfeng Pharmaceuticals Company Information
6.10.2 Xi'an Hanfeng Pharmaceuticals Description and Business Overview
6.10.3 Xi'an Hanfeng Pharmaceuticals GABAB Receptor Agonists Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Xi'an Hanfeng Pharmaceuticals GABAB Receptor Agonists Product Portfolio
6.10.5 Xi'an Hanfeng Pharmaceuticals Recent Developments/Updates
6.11 Sichuan Ren'an Pharmaceuticals
6.11.1 Sichuan Ren'an Pharmaceuticals Company Information
6.11.2 Sichuan Ren'an Pharmaceuticals Description and Business Overview
6.11.3 Sichuan Ren'an Pharmaceuticals GABAB Receptor Agonists Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Sichuan Ren'an Pharmaceuticals GABAB Receptor Agonists Product Portfolio
6.11.5 Sichuan Ren'an Pharmaceuticals Recent Developments/Updates
6.12 China Resources Double Crane Pharmaceuticals
6.12.1 China Resources Double Crane Pharmaceuticals Company Information
6.12.2 China Resources Double Crane Pharmaceuticals Description and Business Overview
6.12.3 China Resources Double Crane Pharmaceuticals GABAB Receptor Agonists Sales, Revenue and Gross Margin (2020-2025)
6.12.4 China Resources Double Crane Pharmaceuticals GABAB Receptor Agonists Product Portfolio
6.12.5 China Resources Double Crane Pharmaceuticals Recent Developments/Updates
6.13 Xi'an Libang Pharmaceuticals
6.13.1 Xi'an Libang Pharmaceuticals Company Information
6.13.2 Xi'an Libang Pharmaceuticals Description and Business Overview
6.13.3 Xi'an Libang Pharmaceuticals GABAB Receptor Agonists Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Xi'an Libang Pharmaceuticals GABAB Receptor Agonists Product Portfolio
6.13.5 Xi'an Libang Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 GABAB Receptor Agonists Industry Chain Analysis
7.2 GABAB Receptor Agonists Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 GABAB Receptor Agonists Production Mode & Process Analysis
7.4 GABAB Receptor Agonists Sales and Marketing
7.4.1 GABAB Receptor Agonists Sales Channels
7.4.2 GABAB Receptor Agonists Distributors
7.5 GABAB Receptor Agonists Customer Analysis
8 GABAB Receptor Agonists Market Dynamics
8.1 GABAB Receptor Agonists Industry Trends
8.2 GABAB Receptor Agonists Market Drivers
8.3 GABAB Receptor Agonists Market Challenges
8.4 GABAB Receptor Agonists Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global GABAB Receptor Agonists Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global GABAB Receptor Agonists Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global GABAB Receptor Agonists Market Competitive Situation by Manufacturers in 2024
 Table 4. Global GABAB Receptor Agonists Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global GABAB Receptor Agonists Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global GABAB Receptor Agonists Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global GABAB Receptor Agonists Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market GABAB Receptor Agonists Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of GABAB Receptor Agonists, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of GABAB Receptor Agonists, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of GABAB Receptor Agonists, Product Type & Application
 Table 12. Global Key Manufacturers of GABAB Receptor Agonists, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global GABAB Receptor Agonists by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GABAB Receptor Agonists as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global GABAB Receptor Agonists Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global GABAB Receptor Agonists Sales by Region (2020-2025) & (K Units)
 Table 18. Global GABAB Receptor Agonists Sales Market Share by Region (2020-2025)
 Table 19. Global GABAB Receptor Agonists Sales by Region (2026-2031) & (K Units)
 Table 20. Global GABAB Receptor Agonists Sales Market Share by Region (2026-2031)
 Table 21. Global GABAB Receptor Agonists Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global GABAB Receptor Agonists Revenue Market Share by Region (2020-2025)
 Table 23. Global GABAB Receptor Agonists Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global GABAB Receptor Agonists Revenue Market Share by Region (2026-2031)
 Table 25. North America GABAB Receptor Agonists Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America GABAB Receptor Agonists Sales by Country (2020-2025) & (K Units)
 Table 27. North America GABAB Receptor Agonists Sales by Country (2026-2031) & (K Units)
 Table 28. North America GABAB Receptor Agonists Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America GABAB Receptor Agonists Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe GABAB Receptor Agonists Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe GABAB Receptor Agonists Sales by Country (2020-2025) & (K Units)
 Table 32. Europe GABAB Receptor Agonists Sales by Country (2026-2031) & (K Units)
 Table 33. Europe GABAB Receptor Agonists Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe GABAB Receptor Agonists Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific GABAB Receptor Agonists Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific GABAB Receptor Agonists Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific GABAB Receptor Agonists Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific GABAB Receptor Agonists Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific GABAB Receptor Agonists Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America GABAB Receptor Agonists Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America GABAB Receptor Agonists Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America GABAB Receptor Agonists Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America GABAB Receptor Agonists Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America GABAB Receptor Agonists Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa GABAB Receptor Agonists Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa GABAB Receptor Agonists Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa GABAB Receptor Agonists Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa GABAB Receptor Agonists Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa GABAB Receptor Agonists Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global GABAB Receptor Agonists Sales (K Units) by Type (2020-2025)
 Table 51. Global GABAB Receptor Agonists Sales (K Units) by Type (2026-2031)
 Table 52. Global GABAB Receptor Agonists Sales Market Share by Type (2020-2025)
 Table 53. Global GABAB Receptor Agonists Sales Market Share by Type (2026-2031)
 Table 54. Global GABAB Receptor Agonists Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global GABAB Receptor Agonists Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global GABAB Receptor Agonists Revenue Market Share by Type (2020-2025)
 Table 57. Global GABAB Receptor Agonists Revenue Market Share by Type (2026-2031)
 Table 58. Global GABAB Receptor Agonists Price (US$/Unit) by Type (2020-2025)
 Table 59. Global GABAB Receptor Agonists Price (US$/Unit) by Type (2026-2031)
 Table 60. Global GABAB Receptor Agonists Sales (K Units) by Application (2020-2025)
 Table 61. Global GABAB Receptor Agonists Sales (K Units) by Application (2026-2031)
 Table 62. Global GABAB Receptor Agonists Sales Market Share by Application (2020-2025)
 Table 63. Global GABAB Receptor Agonists Sales Market Share by Application (2026-2031)
 Table 64. Global GABAB Receptor Agonists Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global GABAB Receptor Agonists Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global GABAB Receptor Agonists Revenue Market Share by Application (2020-2025)
 Table 67. Global GABAB Receptor Agonists Revenue Market Share by Application (2026-2031)
 Table 68. Global GABAB Receptor Agonists Price (US$/Unit) by Application (2020-2025)
 Table 69. Global GABAB Receptor Agonists Price (US$/Unit) by Application (2026-2031)
 Table 70. Novartis Company Information
 Table 71. Novartis Description and Business Overview
 Table 72. Novartis GABAB Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Novartis GABAB Receptor Agonists Product
 Table 74. Novartis Recent Developments/Updates
 Table 75. Hikma Company Information
 Table 76. Hikma Description and Business Overview
 Table 77. Hikma GABAB Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Hikma GABAB Receptor Agonists Product
 Table 79. Hikma Recent Developments/Updates
 Table 80. Viatris Company Information
 Table 81. Viatris Description and Business Overview
 Table 82. Viatris GABAB Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Viatris GABAB Receptor Agonists Product
 Table 84. Viatris Recent Developments/Updates
 Table 85. Jazz Pharmaceuicals Company Information
 Table 86. Jazz Pharmaceuicals Description and Business Overview
 Table 87. Jazz Pharmaceuicals GABAB Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Jazz Pharmaceuicals GABAB Receptor Agonists Product
 Table 89. Jazz Pharmaceuicals Recent Developments/Updates
 Table 90. Sun Pharma Company Information
 Table 91. Sun Pharma Description and Business Overview
 Table 92. Sun Pharma GABAB Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Sun Pharma GABAB Receptor Agonists Product
 Table 94. Sun Pharma Recent Developments/Updates
 Table 95. Fuan Pharmaceutical Group Company Information
 Table 96. Fuan Pharmaceutical Group Description and Business Overview
 Table 97. Fuan Pharmaceutical Group GABAB Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Fuan Pharmaceutical Group GABAB Receptor Agonists Product
 Table 99. Fuan Pharmaceutical Group Recent Developments/Updates
 Table 100. Nanjing Haina Pharmaceutical Company Information
 Table 101. Nanjing Haina Pharmaceutical Description and Business Overview
 Table 102. Nanjing Haina Pharmaceutical GABAB Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Nanjing Haina Pharmaceutical GABAB Receptor Agonists Product
 Table 104. Nanjing Haina Pharmaceutical Recent Developments/Updates
 Table 105. Chengdu Beite Company Information
 Table 106. Chengdu Beite Description and Business Overview
 Table 107. Chengdu Beite GABAB Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Chengdu Beite GABAB Receptor Agonists Product
 Table 109. Chengdu Beite Recent Developments/Updates
 Table 110. Hemony Pharmaceutical Company Information
 Table 111. Hemony Pharmaceutical Description and Business Overview
 Table 112. Hemony Pharmaceutical GABAB Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Hemony Pharmaceutical GABAB Receptor Agonists Product
 Table 114. Hemony Pharmaceutical Recent Developments/Updates
 Table 115. Xi'an Hanfeng Pharmaceuticals Company Information
 Table 116. Xi'an Hanfeng Pharmaceuticals Description and Business Overview
 Table 117. Xi'an Hanfeng Pharmaceuticals GABAB Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Xi'an Hanfeng Pharmaceuticals GABAB Receptor Agonists Product
 Table 119. Xi'an Hanfeng Pharmaceuticals Recent Developments/Updates
 Table 120. Sichuan Ren'an Pharmaceuticals Company Information
 Table 121. Sichuan Ren'an Pharmaceuticals Description and Business Overview
 Table 122. Sichuan Ren'an Pharmaceuticals GABAB Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Sichuan Ren'an Pharmaceuticals GABAB Receptor Agonists Product
 Table 124. Sichuan Ren'an Pharmaceuticals Recent Developments/Updates
 Table 125. China Resources Double Crane Pharmaceuticals Company Information
 Table 126. China Resources Double Crane Pharmaceuticals Description and Business Overview
 Table 127. China Resources Double Crane Pharmaceuticals GABAB Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. China Resources Double Crane Pharmaceuticals GABAB Receptor Agonists Product
 Table 129. China Resources Double Crane Pharmaceuticals Recent Developments/Updates
 Table 130. Xi'an Libang Pharmaceuticals Company Information
 Table 131. Xi'an Libang Pharmaceuticals Description and Business Overview
 Table 132. Xi'an Libang Pharmaceuticals GABAB Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Xi'an Libang Pharmaceuticals GABAB Receptor Agonists Product
 Table 134. Xi'an Libang Pharmaceuticals Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. GABAB Receptor Agonists Distributors List
 Table 138. GABAB Receptor Agonists Customers List
 Table 139. GABAB Receptor Agonists Market Trends
 Table 140. GABAB Receptor Agonists Market Drivers
 Table 141. GABAB Receptor Agonists Market Challenges
 Table 142. GABAB Receptor Agonists Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of GABAB Receptor Agonists
 Figure 2. Global GABAB Receptor Agonists Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global GABAB Receptor Agonists Market Share by Type: 2024 & 2031
 Figure 4. Baclofen Product Picture
 Figure 5. γ-hydroxybutyrate(GHB)) Product Picture
 Figure 6. Global GABAB Receptor Agonists Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global GABAB Receptor Agonists Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Other
 Figure 11. Global GABAB Receptor Agonists Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global GABAB Receptor Agonists Market Size (2020-2031) & (US$ Million)
 Figure 13. Global GABAB Receptor Agonists Sales (2020-2031) & (K Units)
 Figure 14. Global GABAB Receptor Agonists Average Price (US$/Unit) & (2020-2031)
 Figure 15. GABAB Receptor Agonists Report Years Considered
 Figure 16. GABAB Receptor Agonists Sales Share by Manufacturers in 2024
 Figure 17. Global GABAB Receptor Agonists Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest GABAB Receptor Agonists Players: Market Share by Revenue in GABAB Receptor Agonists in 2024
 Figure 19. GABAB Receptor Agonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global GABAB Receptor Agonists Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America GABAB Receptor Agonists Sales Market Share by Country (2020-2031)
 Figure 22. North America GABAB Receptor Agonists Revenue Market Share by Country (2020-2031)
 Figure 23. United States GABAB Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada GABAB Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe GABAB Receptor Agonists Sales Market Share by Country (2020-2031)
 Figure 26. Europe GABAB Receptor Agonists Revenue Market Share by Country (2020-2031)
 Figure 27. Germany GABAB Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France GABAB Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. GABAB Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy GABAB Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia GABAB Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific GABAB Receptor Agonists Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific GABAB Receptor Agonists Revenue Market Share by Region (2020-2031)
 Figure 34. China GABAB Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan GABAB Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea GABAB Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India GABAB Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia GABAB Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan GABAB Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia GABAB Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America GABAB Receptor Agonists Sales Market Share by Country (2020-2031)
 Figure 42. Latin America GABAB Receptor Agonists Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico GABAB Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil GABAB Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina GABAB Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Colombia GABAB Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa GABAB Receptor Agonists Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa GABAB Receptor Agonists Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey GABAB Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia GABAB Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE GABAB Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of GABAB Receptor Agonists by Type (2020-2031)
 Figure 53. Global Revenue Market Share of GABAB Receptor Agonists by Type (2020-2031)
 Figure 54. Global GABAB Receptor Agonists Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of GABAB Receptor Agonists by Application (2020-2031)
 Figure 56. Global Revenue Market Share of GABAB Receptor Agonists by Application (2020-2031)
 Figure 57. Global GABAB Receptor Agonists Price (US$/Unit) by Application (2020-2031)
 Figure 58. GABAB Receptor Agonists Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure